The aims of this review are to highlight the current understanding of S100A10 function in cancer cells—with a particular focus on ovarian cancer—and to discuss the potential for using S100A10 as a predictive marker and targeting S100A10 to inhibit cancer progression and treatment resistance. Here, S100A10 is linked to ovarian carcinoma.